Travere Therapeutics, Inc.

TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001438533

Price chart

Open-market purchases and sales by TVTX insiders, newest first.

Insider trades
Filed (ET)Trade dateInsiderTransactionSharesAvg priceValueShares afterHolding changeFiling
Sep 17, 20269:35 PM ETSep 15 – Sep 16, 2026ROTE WILLIAM E.Chief Research OfficerSSaleCommon Stock−209.05K$62.8344−$13.14M98.2K−68.0%SEC10b5-1
Sep 17, 20269:35 PM ETSep 15 – Sep 17, 2026Heerma PeterEVP, CHIEF COMMERCIAL OFFICERSSaleCommon Stock−283.19K$63.0598−$17.86M117.07K−70.8%SEC10b5-1
Sep 17, 20269:33 PM ETSep 15, 2026Inrig JulaEVP, Head of R&D & CMOSSaleCommon Stock−44.67K$62.341−$2.79M100.49K−30.8%SEC10b5-1
Sep 17, 20269:32 PM ETSep 15, 2026REED ELIZABETH EChief Legal Officer and GCSSaleCommon Stock−37.5K$62.3385−$2.34M105.39K−26.2%SEC10b5-1
Sep 17, 20269:31 PM ETSep 15 – Sep 17, 2026Dube Eric MCHIEF EXECUTIVE OFFICERSSaleCommon Stock−400K$63.4768−$25.39M432.89K−48.0%SEC10b5-1

The largest institutional positions in TVTX at the end of Q2 2026.

Institutions holding TVTX in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Jupiter Topco LLC11,324,191$643.3M0.26%+11,324,191New
BlackRock, Inc.8,020,663$515.26M0.01%+228,630+2.9%Added
FMR LLC7,096,614$407.87M0.02%−3,871,353−35.3%Reduced
BANK OF AMERICA CORP /DE/4,568,341$259.53M0.02%+3,223,230+239.6%Added
STATE STREET CORP4,256,224$256.71M0.01%−703,764−14.2%Reduced